English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
e
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Login
Videos
[1966]
News
[3746]
Articles
[98]
Editorials
[5]
Conferences
[165]
e
learning
[19]
Research:
Characteristics of relapsed and refractory paediatric Hodgkin lymphoma; a 10-year retrospective study of an LMIC
Quratulain Riaz,
Rabel Gul,
Vashma Junaid,
Wasfa Farooq,
Naema Khayyam
16 Jul 2024
https://doi.org/10.3332/ecancer.2024.1729
Abstract
|
Full Article
|
PDF
Research:
Subcutaneous versus intravenous administration of Trastuzumab: a minimization cost analysis with real world data from a reference cancer centre in Peru
Iris Otoya,
Natalia Valdiviezo,
Katia Roque,
Zaida Morante,
Tatiana Vidaurre,
Silvia P. Neciosup,
Mónica J. Calderón,
Henry L. Gomez
31 May 2024
https://doi.org/10.3332/ecancer.2024.1708
Abstract
|
Full Article
|
PDF
Research:
Clinical characteristics, outcomes and prognostic factors in KRAS mutant lung cancers: experience from a tertiary care cancer center in India
Vanita Noronha,
Laboni Sarkar,
Vijay Patil,
Nandini Menon,
Minit Shah,
Akash Pawar,
Oindrila Roy Chowdhury,
Omshree Shetty,
Anuradha Chougule,
Pratik Chandrani,
Rajiv Kaushal,
Trupti Pai,
Amit Janu,
Nivedita Chakrabarty,
Kumar Prabhash
22 Feb 2024
https://doi.org/10.3332/ecancer.2024.1674
Abstract
|
Full Article
|
PDF
Case Report:
Re-challenge of immune checkpoint inhibitor pembrolizumab with concurrent tocilizumab after prior grade 3 pneumonitis
Chitrakshi Nagpal,
Sameer Rastogi,
Shamim A Shamim,
Sneha Prakash
8 Dec 2023
https://doi.org/10.3332/ecancer.2023.1644
Abstract
|
Full Article
|
PDF
Case Report:
Successful long-term management of metastatic clear cell renal cell carcinoma with nivolumab: a case report and literature review
Nicolás Duque Clavijo,
Paula A Lara,
John Alejandro Murillo Silva,
Iván Camilo Triana,
Henry Alexander Vargas,
Luis Eduardo Pino,
Javier Mauricio Segovia,
Erick Andrés Cantor
30 Nov 2023
https://doi.org/10.3332/ecancer.2023.1643
Abstract
|
Full Article
|
PDF
Research:
EpCAM expression negatively regulates E-cadherin function in colorectal carcinomas
Uchenna Simon Ezenkwa,
Gabriel Olabiyi Ogun,
Mbwas Isaac Mashor,
Olufemi John Ogunbiyi
6 Jul 2023
https://doi.org/10.3332/ecancer.2023.1569
Abstract
|
Full Article
|
PDF
Review:
Myeloid-derived suppressor cells (MDSCs): what do we currently know about the effect they have against anti-PD-1/PD-L1 therapies?
Ronald Sergio Limón Tellez,
Lucia Reynolds,
Miguel A Piris
5 Jun 2023
https://doi.org/10.3332/ecancer.2023.1556
Abstract
|
Full Article
|
PDF
Research:
Real-world analysis of the use of lenvatinib in differentiated thyroid cancers
Zoya Peelay,
Deevyashali Parekh,
Vijay M Patil,
Vanita Noronha,
Nandini Menon,
Kumar Prabhash
30 Jan 2023
https://doi.org/10.3332/ecancer.2023.1500
Abstract
|
Full Article
|
PDF
Review:
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
Rodrigo Motta Guerrero,
Veronica Arnao Labajos,
Sophia Lozano Ballena,
Carlos Aliaga Macha,
Miguel Sotelo Lezama,
Cristian Pacheco Roman,
Paola Montenegro Beltran,
Alejandro Figueroa Torrejon
15 Dec 2022
https://doi.org/10.3332/ecancer.2022.1489
Abstract
|
Full Article
|
PDF
Research:
Retrospective analysis: checkpoint inhibitor accessibility for thoracic and head and neck cancers and factors influencing it in a tertiary centre in India
Vijay Patil,
George Abraham,
Madala Ravikrishna,
Atanu Bhattacharjee,
Vanita Noronha,
Deevyashali Parekh,
Nandini Menon,
Jyoti Bajpai,
Kumar Prabhash
3 Nov 2022
https://doi.org/10.3332/ecancer.2022.1464
Abstract
|
Full Article
|
PDF
<
1
2
3
4
5
…
10
>
More from
e
cancer